Covalon Technologies (CVE:COV) Trading Up 2.1% – Should You Buy?

Covalon Technologies Ltd. (CVE:COVGet Free Report)’s share price was up 2.1% during trading on Tuesday . The company traded as high as C$1.99 and last traded at C$1.99. Approximately 320 shares were traded during trading, a decline of 97% from the average daily volume of 12,055 shares. The stock had previously closed at C$1.95.

Covalon Technologies Stock Performance

The firm has a market capitalization of C$55.24 million, a price-to-earnings ratio of 66.67 and a beta of 1.11. The company has a quick ratio of 6.45, a current ratio of 5.69 and a debt-to-equity ratio of 7.82. The stock has a 50-day moving average price of C$1.88 and a 200 day moving average price of C$1.83.

Covalon Technologies Company Profile

(Get Free Report)

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.

See Also

Receive News & Ratings for Covalon Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covalon Technologies and related companies with MarketBeat.com's FREE daily email newsletter.